Eko Health developed an AI algorithm that, combined with noninvasive heart tests, may be able to accurately identify pulmonary hypertension.

The following is a summary of “Differences between private and public primary health care centers and differences between men and women in antihypertensive care and cardiovascular prevention in all ...

Inhibiting GLS1 reduced high blood pressure in the right side of the heart of PAH rats and improved various measures of heart ...

High blood pressure is a major risk factor for heart disease. Here are some common questions you may have about blood ...

Seropositive rheumatoid arthritis may be protective against the development of PAH, based on results of Mendelian randomization analyses.

The following is a summary of “Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with ...

Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 millionReceived CE Mark for LungFit PH® in ...

Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, today ...

Eko Health has been advancing the use of artificial intelligence to help providers detect the early signs of disease, ...

Finding it hard to breathe when you lay down is medically called orthopnea. Find a list of potential causes to help narrow ...

There are three primary types: orthostatic hypotension, neurally mediated hypotension, and severe hypotension related to shock, which is a medical emergency. Learn More Causes and Risk Factors of Low ...

The phase 3 HYPERION trial of Winrevair in adults with newly diagnosed pulmonary arterial hypertension functional class two ...